Earlier this week, positive results were released from a clinical study testing a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) as a treatment in recurrent glioblastoma (GBM) patients in the UK.

Researchers at the University of Adelaide have developed a novel piece of technology that acts as a tiny flashlight, allowing surgeons to see in to the brain. This machinery could transform neurosurgery for both patients and doctors.

BBC Children in Need and St James’s Place Foundation have awarded grants totalling over £208,000 to The Brain Tumour Charity’s support services.

On Monday The Brain Tumour Charity attended the second meeting of the task and finish working group on research into brain tumour (TFWG) which was set up by the Department of Health to address barriers to research.

Policy Officer, James Thorneycroft, discusses how leaving the EU could affect research into brain tumours.

The cause behind millions of cases of food poisoning has been surprisingly effective in crossing the blood brain barrier to reach tumour sites. Researchers at Duke University genetically modified the bacteria Salmonella to enable it to seek out and attack glioblastoma tumour cells in animal models.

Scientists at the University of Leeds have discovered that targeting a protein that helps cancer cells repair their DNA could lead to a new treatment for the highly aggressive brain tumour, glioblastoma (GBM).

Claire Lloyd came across our HeadSmart website, which lists the most common signs of childhood brain tumours, after her nine-year-old son Jack had been vomiting regularly during the day for more than a week.

David Jenkinson, Chief Scientific Officer at The Brain Tumour Charity, discusses laying foundations for more effective brain tumour treatments.

HeadSmart has already helped cut the average diagnosis time for a childhood brain tumour in the UK from more than 13 weeks to 6.5 weeks.

A combinatorial approach using immunotherapy and gene therapy has been explored by researchers at the University of Michigan against the highly aggressive brain tumour, glioblastoma (GBM).

The Brain Tumour Charity have collaborated with NHS England to better understand the role of Clinical Nurse Specialists (CNS) and Keyworkers who work with people affected by brain tumours.

In response to overwhelming concerns from our community The Brain Tumour Charity met with the Driver and Vehicle Licensing Agency (DVLA) in Swansea to discuss issues around driving and brain tumours.

A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.

Grace, 23, recently filmed her first video blog for us where she asked our community for any questions about diagnosis, symptoms and effects and life after surgery. Her honest and heartfelt answers are now documented in a video diary.

A report today from Cancer Research UK predicts that survival from brain tumours will remain virtually unchanged over the next 20 years, despite an expected fall of 15% overall in the number of cancer deaths by 2035.

Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.

The Biobanking Consensus Meeting, initiated by us, is being held at Islington’s Business Design Centre in London.

Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).

A drug that can extend the lives of brain tumour patients is being withheld by some NHS Trusts on the grounds of cost.

Due to be operational in 2018, a new Proton Beam centre has just received planning permission this week. Building work has already begun on the University of Reading’s site for their Thames Valley Science Park.

In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

Beccy Shortt, our Senior Policy and Public Affairs Manager at The Brain Tumour Charity explores the barriers surrounding brain tumour research.

Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.